R&D Meets The Crowdscape: BioMed X Looks Outside For Insight
An extended inter-disciplinary approach to preclinical research may offer the best leads against today’s biggest challenges in medicine.
• By William Looney
Crowd science appeals as a remedy for declining productivity in the biopharma pipeline • Source: Gayle Rembold Furbert 
